Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Susanna Esposito & Nicola Principi$suffix/text()$suffix/text(). (2017) Strategies to develop vaccines of pediatric interest. Expert Review of Vaccines 16:2, pages 175-186.
Read now
Read now
Gabrielle R Andrade, Roger R C New, Osvaldo A Sant’Anna, Neil A Williams, Rosely C B Alves, Daniel C Pimenta, Hugo Vigerelli, Bruna S Melo, Letícia B Rocha, Roxane M F Piazza, Lucia Mendonça-Previato & Marta O Domingos. (2014) A universal polysaccharide conjugated vaccine against O111 E. coli. Human Vaccines & Immunotherapeutics 10:10, pages 2864-2874.
Read now
Read now
Ruth Mitchell, Dominic F Kelly, Andrew J Pollard & Johannes Trück. (2014) Polysaccharide-specific B cell responses to vaccination in humans. Human Vaccines & Immunotherapeutics 10:6, pages 1661-1668.
Read now
Read now
Zach Z Liang, Ashley M Sherrid, Anu Wallecha & Tobias R Kollmann. (2014) Listeria monocytogenes. Human Vaccines & Immunotherapeutics 10:4, pages 1036-1046.
Read now
Read now
Seon Hee Shin & Kwang Sik Kim. (2012) Treatment of bacterial meningitis: an update. Expert Opinion on Pharmacotherapy 13:15, pages 2189-2206.
Read now
Read now
Eleanor Barnes & Andrew J Pollard. (2011) Vaccines in clinical trials: infectious disease. Expert Review of Vaccines 10:5, pages 555-557.
Read now
Read now
Articles from other publishers (40)
Amir Elalouf, Tomer Kedarya, Hadas Elalouf & Ariel Rosenfeld. (2023) Computational design and evaluation of mRNA- and protein-based conjugate vaccines for influenza A and SARS-CoV-2 viruses. Journal of Genetic Engineering and Biotechnology 21:1.
Crossref
Crossref
J. Nagel, G. Jönsson, J-Å. Nilsson, C. Manuswin, M. Englund, T. Saxne & M.C. Kapetanovic. (2023) Reduced risk of serious pneumococcal infections up to 10 years after a dose of pneumococcal conjugate vaccine in established arthritis. Vaccine 41:2, pages 504-510.
Crossref
Crossref
Keith P. Klugman, Richard Malley & Cynthia G. Whitney. 2023. Plotkin's Vaccines. Plotkin's Vaccines
826
868.e18
.
Grant A. Mackenzie, Isaac Osei, Rasheed Salaudeen, Ilias Hossain, Benjamin Young, Ousman Secka, Umberto D’Alessandro, Arto A. Palmu, Jukka Jokinen, Jason Hinds, Stefan Flasche, Kim Mulholland, Cattram Nguyen & Brian Greenwood. (2022) A cluster-randomised, non-inferiority trial of the impact of a two-dose compared to three-dose schedule of pneumococcal conjugate vaccination in rural Gambia: the PVS trial. Trials 23:1.
Crossref
Crossref
Grant A. Mackenzie, Isaac Osei, Rasheed Salaudeen, Ousman Secka, Umberto D’Alessandro, Ed Clarke, Jonas Schmidt-Chanasit, Paul V. Licciardi, Cattram Nguyen, Brian Greenwood & Kim Mulholland. (2022) Pneumococcal conjugate vaccination schedules in infants—acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study. Trials 23:1.
Crossref
Crossref
Sara Pischedda, Daniel O’Connor, Benjamin P. Fairfax, Antonio Salas, Federico Martinon-Torres, Andrew J. Pollard & Johannes Trück. (2021) Changes in epigenetic profiles throughout early childhood and their relationship to the response to pneumococcal vaccination. Clinical Epigenetics 13:1.
Crossref
Crossref
Sumudu R. Perera, Akosiererem S. Sokaribo & Aaron P. White. (2021) Polysaccharide Vaccines: A Perspective on Non-Typhoidal Salmonella. Polysaccharides 2:3, pages 691-714.
Crossref
Crossref
Gianmarco Gasperini, Maria Michelina Raso, Vanessa Arato, Maria Grazia Aruta, Paola Cescutti, Francesca Necchi & Francesca Micoli. (2021) Effect of O-Antigen Chain Length Regulation on the Immunogenicity of Shigella and Salmonella Generalized Modules for Membrane Antigens (GMMA). International Journal of Molecular Sciences 22:3, pages 1309.
Crossref
Crossref
E. A. Khatuntseva & N. E. Nifantiev. (2021) Glycoconjugate Vaccines for Prevention of Haemophilus influenzae Type b Diseases. Russian Journal of Bioorganic Chemistry 47:1, pages 26-52.
Crossref
Crossref
Philippe De Wals. (2019) Epidemiology and Control of Meningococcal Disease in Canada: A Long, Complex, and Unfinished Story. Canadian Journal of Infectious Diseases and Medical Microbiology 2019, pages 1-11.
Crossref
Crossref
Si-On Lee, Seungyeop Lee, Se-Jin Kim & Dong-Kwon Rhee. (2019) Korean Red Ginseng enhances pneumococcal Δpep27 vaccine efficacy by inhibiting reactive oxygen species production. Journal of Ginseng Research 43:2, pages 218-225.
Crossref
Crossref
Se-Jin Kim, Seung Han Seon, Truc Thanh Luong, Prachetash Ghosh, Suhkneung Pyo & Dong-Kwon Rhee. (2019) Immunization with attenuated non-transformable pneumococcal pep27 and comD mutant provides serotype-independent protection against pneumococcal infection. Vaccine 37:1, pages 90-98.
Crossref
Crossref
Nicholas J. Croucher, Alessandra Løchen & Stephen D. Bentley. (2018) Pneumococcal Vaccines: Host Interactions, Population Dynamics, and Design Principles. Annual Review of Microbiology 72:1, pages 521-549.
Crossref
Crossref
David Bundle, Eugenia Paszkiewicz, Hassan Elsaidi, Satadru Mandal & Susmita Sarkar. (2018) A Three Component Synthetic Vaccine Containing a β-Mannan T-Cell Peptide Epitope and a β-Glucan Dendritic Cell Ligand. Molecules 23:8, pages 1961.
Crossref
Crossref
Dapeng Zhou, Lan Xu, Wei Huang & Torsten Tonn. (2018) Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy. Molecules 23:6, pages 1326.
Crossref
Crossref
Els van Westen, Martien C. M. Poelen, Germie P. J. M. van den Dobbelsteen, Eliud O. Oloo, Martina M. Ochs, Nynke Y. Rots & Cecile A. C. M. van Els. (2018) Immunodominance in T cell responses elicited against different domains of detoxified pneumolysin PlyD1. PLOS ONE 13:3, pages e0193650.
Crossref
Crossref
Keith P. Klugman, Ron Dagan, Richard Malley & Cynthia G. Whitney. 2018. Plotkin's Vaccines. Plotkin's Vaccines
773
815.e18
.
Vianca Vianzon, Beate Illek & Gregory R. Moe. (2017) Effect of Vaccine-Elicited Antibodies on Colonization of Neisseria meningitidis Serogroup B and C Strains in a Human Bronchial Epithelial Cell Culture Model. Clinical and Vaccine Immunology 24:10.
Crossref
Crossref
Nikolas T. Weissmueller, Leanne Marsay, Heiko A. Schiffter, Robert C. Carlisle, Christine S. Rollier, Robert K. Prud’homme & Andrew J. Pollard. (2017) Alternative vaccine administration by powder injection: Needle-free dermal delivery of the glycoconjugate meningococcal group Y vaccine. PLOS ONE 12:8, pages e0183427.
Crossref
Crossref
Gyu-Lee Kim, Sang-Yoon Choi, Seung-Han Seon, Seungyeop Lee, Sang-Sang Park, Joon Young Song, David E. Briles & Dong-Kwon Rhee. (2016) Pneumococcal pep27 mutant immunization stimulates cytokine secretion and confers long-term immunity with a wide range of protection, including against non-typeable strains. Vaccine 34:51, pages 6481-6492.
Crossref
Crossref
L. A. Lisitskaya, A. V. Kolesnikov, A. V. Kozyr, I. G. Shemyakin, A. K. Ryabko, O. N. Krasavtseva & LA. .. Dyatlov. (2016) PROTEINS AND OTHER CARRIERS FOR CREATION OF CONJUGATED VACCINES: PROPERTIES AND APPLICATION. Journal of microbiology, epidemiology and immunobiology 93:4, pages 115-124.
Crossref
Crossref
E. A. Yagovkin, G. G. Onishchenko, A. Yu. Popova, E. B. Ezhlova, A. A. Melnikova, M. Yu. Soloviev, E. V. Kovalev, T. I. Tverdokhlebova, G. V. Khmelevskaya, L. V. Devterova, B. F. Vachaev & I. L. Yuryeva. (2016) Condition and Prospects of Development of Vaccines for Specific Prevention of Enterovirus (Nonpolio) Infection. Epidemiology and Vaccine Prevention 15:4, pages 74-82.
Crossref
Crossref
G. K. Bårnes, B. Workalemahu, P. A. Kristiansen, D. Beyene, B. Merdekios, P. Fissiha, A. Aseffa, D. A. Caugant & L. M. Næss. (2016)
Salivary and Serum Antibody Response Against
Neisseria meningitidis
After Vaccination With Conjugate Polysaccharide Vaccines in Ethiopian Volunteers
. Scandinavian Journal of Immunology 84:2, pages 118-129.
Crossref
Crossref
Alienke J. Wijmenga-Monsuur, Els van Westen, Mirjam J. Knol, Riet M. C. Jongerius, Marta Zancolli, David Goldblatt, Pieter G. M. van Gageldonk, Irina Tcherniaeva, Guy A. M. Berbers & Nynke Y. Rots. (2015) Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants. PLOS ONE 10:12, pages e0144739.
Crossref
Crossref
Els van Westen, Alienke J. Wijmenga-Monsuur, Harry H. van Dijken, Jacqueline A. M. van Gaans-van den Brink, Betsy Kuipers, Mirjam J. Knol, Guy A. M. Berbers, Elisabeth A. M. Sanders, Nynke Y. Rots & Cécile A. C. M. van Els. (2015) Differential B-Cell Memory Around the 11-Month Booster in Children Vaccinated With a 10- or 13-Valent Pneumococcal Conjugate Vaccine. Clinical Infectious Diseases 61:3, pages 342-349.
Crossref
Crossref
Ajoke Sobanjo-ter Meulen, Timo Vesikari, Edgardo A. Malacaman, Steven A. Shapiro, Michael J. Dallas, Patricia A. Hoover, Richard McFetridge, Jon E. Stek, Rocio D. Marchese, Jonathan Hartzel, Wendy J. Watson & Luwy K. Musey. (2015) Safety, Tolerability and Immunogenicity of 15-valent Pneumococcal Conjugate Vaccine in Toddlers Previously Vaccinated With 7-valent Pneumococcal Conjugate Vaccine. Pediatric Infectious Disease Journal 34:2, pages 186-194.
Crossref
Crossref
A. Torres, P. Bonanni, W. Hryniewicz, M. Moutschen, R. R. Reinert & T. Welte. (2014) Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?. European Journal of Clinical Microbiology & Infectious Diseases 34:1, pages 19-31.
Crossref
Crossref
Martin C. J. Maiden. (2013) The impact of protein-conjugate polysaccharide vaccines: an endgame for meningitis?. Philosophical Transactions of the Royal Society B: Biological Sciences 368:1623, pages 20120147.
Crossref
Crossref
Geraldine Blanchard-Rohner, Matthew D. Snape, Dominic F. Kelly, Daniel O’Connor, Tessa John, Elizabeth Kibwana, Hannah Parks, Karen Ford, Peter M. Dull & Andrew J. Pollard. (2013) Seroprevalence and Placental Transmission of Maternal Antibodies Specific for Neisseria meningitidis Serogroups A, C, Y and W135 and Influence of Maternal Antibodies on the Immune Response to a Primary Course of MenACWY-CRM Vaccine in the United Kingdom. Pediatric Infectious Disease Journal 32:7, pages 768-776.
Crossref
Crossref
David Tuerlinckx, Julie Smet, Iris De Schutter, Jacques Jamart, Anne Vergison, Marc Raes, Pierre R. Smeesters, Jan Verhaegen, Filip Surmont, Anne Malfroot & Françoise Mascart. (2013) Evaluation of a WHO-validated Serotype-specific Serological Assay for the Diagnosis of Pneumococcal Etiology in Children With Community-acquired Pneumonia. Pediatric Infectious Disease Journal 32:7, pages e277-e284.
Crossref
Crossref
Ofer Levy, Stanislas Goriely & Tobias R. Kollmann. (2013) Immune response to vaccine adjuvants during the first year of life. Vaccine 31:21, pages 2500-2505.
Crossref
Crossref
Johan N Siebert, Arnaud G L’Huillier, Stéphane Grillet, Cécile Delhumeau, Claire-Anne Siegrist & Klara M Posfay-Barbe. (2013) Memory B cell compartment constitution and susceptibility to recurrent lower respiratory tract infections in young children. Journal of Leukocyte Biology 93:6, pages 951-962.
Crossref
Crossref
Thomas A. Russo, Janet M. Beanan, Ruth Olson, Ulrike MacDonald, Andrew D. Cox, Frank St. Michael, Evgeny V. Vinogradov, Brad Spellberg, Nicole R. Luke-Marshall & Anthony A. Campagnari. (2013) The K1 Capsular Polysaccharide from Acinetobacter baumannii Is a Potential Therapeutic Target via Passive Immunization. Infection and Immunity 81:3, pages 915-922.
Crossref
Crossref
Johannes Trück, Rajeka Lazarus, Elizabeth A. Clutterbuck, Jaclyn Bowman, Elizabeth Kibwana, Elizabeth A.L. Bateman & Andrew J. Pollard. (2013) The zwitterionic type I Streptococcus pneumoniae polysaccharide does not induce memory B cell formation in humans. Immunobiology 218:3, pages 368-372.
Crossref
Crossref
Joachim Luthander, Rutger Bennet, Christian G Giske, Anna Nilsson & Margareta Eriksson. (2013) Age and risk factors influence the microbial aetiology of bloodstream infection in children. Acta Paediatrica 102:2, pages 182-186.
Crossref
Crossref
Keith P. Klugman, Steven Black, Ron Dagan, Richard Malley & Cynthia G. Whitney. 2013. Vaccines. Vaccines
504
541
.
Michael Cunningham, Elizabeth Guardiani, Hung Jeffrey Kim & Itzhak Brook. (2012) Otitis media. Future Microbiology 7:6, pages 733-753.
Crossref
Crossref
Miguel OrtínMuhammad A Saif. (2012) How necessary is it to revaccinate hemopoietic transplant recipients?. Immunotherapy 4:5, pages 461-464.
Crossref
Crossref
Steven B. Black & Stanley A. Plotkin. (2012) Meningococcal disease from the public health policy perspective. Vaccine 30, pages B37-B39.
Crossref
Crossref
Brenda E. Clark, Kate Auyeung, Eleonora Fregolino, Michelangelo Parrilli, Rosa Lanzetta, Cristina De Castro & Ralph Pantophlet. (2012) A Bacterial Lipooligosaccharide that Naturally Mimics the Epitope of the HIV-Neutralizing Antibody 2G12 as a Template for Vaccine Design. Chemistry & Biology 19:2, pages 254-263.
Crossref
Crossref